Reporter
Weisman covers the healthcare and life sciences industries for the Business section. He was a business reporter and editor for the Hartford Courant and the Seattle Times before joining the Globe in 2000.
Latest stories
Net income rises for Partners HealthCare System
By Robert Weisman , Globe Staff
Earnings rose despite a state decision to drop an assessment on the insurer’s newly acquired health insurance division.
Novartis, Amgen join venture fund
By Robert Weisman , Globe Staff
Biopharmaceutical companies Novartis AG and Amgen Inc. have signed on as limited partners in a new $265 million venture capital fund.
Algeta wins FDA approval for prostate cancer treatment
By Robert Weisman , Globe Staff
The drug, called Xofigo, treats castration-resistant prostate cancer, a disease that afflicts tens of thousands of men in the US.
State health insurers post mixed financial results
By Robert Weisman , Globe Staff
Two of the state’s biggest health insurance companies reported income gains, one registered lower earnings, and one posted a loss.